Health Care Companies Release Financial Results and Announce Earnings Schedules - Research Report on Opko, Sirona Dental,

    Health Care Companies Release Financial Results and Announce Earnings
   Schedules - Research Report on Opko, Sirona Dental, Accuray, Techne, and
                                    Steris

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

NEW YORK, August 21, 2013

NEW YORK, August 21, 2013 /PRNewswire/ --

Today, Investors' Reports announced new research reports highlighting Opko
Health, Inc. (NYSE: OPK), Sirona Dental Systems Inc. (NASDAQ: SIRO), Accuray
Incorporated (NASDAQ: ARAY), Techne Corp. (NASDAQ: TECH), and Steris Corp.
(NYSE: STE). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings - via the
links below.

Opko Health, Inc. Research Report

On August 9, 2013, Opko Health, Inc. (Opko) reported its Q2 2013 financial
results with consolidated revenues of $23.8 million, compared to $10.2 million
in Q2 2012. Net loss for the quarter totaled $3.4 million, compared to net
loss of $10.8 million in Q2 2012. "We continue to build and strengthen the
foundation for a sound profitable business," said Phillip Frost, M.D., OPKO's
Chairman and CEO. "We are also very proud of the pipeline of new products in
various stages of development in OPKO and soon to be acquired PROLOR. They can
provide the basis for an important health care company." The Full Research
Report on Opko Health, Inc. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
[http://www.investorsreports.com/report/2013-08-14/OPK]

Sirona Dental Systems Inc. Research Report

On August 2, 2013, Sirona Dental Systems Inc. (Sirona) reported its Q3 FY 2013
financial results (period ended June 30, 2013) with revenue growth of 17.0%
YoY to $283.2 million. Gross profit margin was 53.5% compared to 53.1% in Q3
FY 2012. Net income came in at $40.6 million or $0.72 per diluted share,
higher compared to $30.3 million or $0.53 per diluted share in Q3 FY 2012.
Commenting on the Company's future outlook, Jeffrey Slovin, President and CEO
of Sirona said, "We are on track for a third consecutive year of double digit
revenue growth clearly demonstrating the strength of our organization. We
continue to take market share and are well positioned for future growth." The
Full Research Report on Sirona Dental Systems Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at: [http://www.investorsreports.com/report/2013-08-14/SIRO]

Accuray Incorporated Research Report

On August 7, 2013, Accuray Inc. (Accuray) announced that it has scheduled to
release its Q4 FY 2013 and full-year FY 2013 (period ended June 30, 2013)
financial results on August 27, 2013, after the market closes. On the same
day, the Company will hold a conference call at 2:00 p.m. PDT to discuss the
results, which will be hosted by Joshua H. Levine, President and CEO and Derek
Bertocci, Senior Vice President and CFO. The Full Research Report on Accuray
Incorporated - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:
[http://www.investorsreports.com/report/2013-08-14/ARAY]

Techne Corp. Research Report

On August 6, 2013, Techne Corp. (Techne) reported its Q4 FY 2013 and full-year
FY 2013 financial results (period ended June 30, 2013). Net sales for the
quarter totaled $79.5 million, up 1.0% YoY. Q4 FY 2013 earnings totaled $28.4
million or $0.77 per diluted share, as compared with $27.2 million or $0.74
per diluted share in Q4 FY 2012. For full-year FY 2013, net sales declined
1.3% YoY to $310.6 million. The Company reported that a stronger U.S. dollar
as compared to foreign currencies reduced year-on-year sales by $2.6 million
in full-year FY 2013. Earnings for the full-year FY 2013 came in at $112.6
million or $3.05 per diluted share, as compared with $112.3 million or $3.04
per diluted share in FY 2012. The Full Research Report on Techne Corp. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.investorsreports.com/report/2013-08-14/TECH]

Steris Corp. Research Report

On August 7, 2013, Steris Corp. (Steris) reported its Q1 FY 2014 financial
results (period ended June 30, 2013). Revenues for the quarter increased to
$367.7 million, compared with $337.0 million in Q1 FY 2013. Net income came in
at $32.3 million or $0.54 per diluted share, slightly higher compared with net
income of $30.4 million or $0.52 per diluted share in Q1 FY 2013. Commenting
on the future outlook of the Company, Walt Rosebrough, President and CEO of
STERIS said, "We continue to see stable market trends, good performance from
the businesses we recently acquired, and strong Healthcare orders and backlog,
which gives us confidence in our ability to deliver revenue and earnings
in-line with our guidance for the year." The Company re-affirmed its outlook
for full-year FY 2014 with revenue growth in the range of 8% to 10% YoY and
adjusted EPS in the range of $2.47 to $2.60. The Full Research Report on
Steris Corp. - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:
[http://www.investorsreports.com/report/2013-08-14/STE]

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

www.InvestorsReports.com

SOURCE Investors' Reports

Contact: Kristi Saunders, +1-315-982-6420 (North America)